A Breathless Builder

Total Page:16

File Type:pdf, Size:1020Kb

A Breathless Builder case presentations no03.qxd 17/05/2007 15:38 Page 2 CASE PRESENTATION A breathless builder J.J. Lyons1 P.J. Sime1 Case report hand-grinder, a common task known as "tuck- D. Ward2 The patient was a 30-year-old male mason whose pointing" (figure 2), while intermittently using a T. Watson3 work frequently involved cutting and grinding disposable particle mask. After completing this J.L. Abraham4 brick and cement with powered tools. He was an job, he felt well for ~2 months and then gradu- R. Evans5 active smoker (1–1.5 packs per day). He had ally began to develop a nonproductive cough, 6 M. Budev worked in building construction since the age of dyspnoea on exertion and an 11 kg weight loss K. Costas3 W.S. Beckett1 14 yrs, as a labourer then as a mason and had without fever. Serial pulmonary function testing been a mason for the previous 13 years. He showed restriction and a marked reduction in dif- reported frequent exposure to cement and brick fusing capacity. Chest computed tomography 1Division of Pulmonary and dust while removing stone floors with a jackham- (CT) showed bilateral diffuse infiltrates. A purified Critical Care Medicine, 2Dept of mer. From 8–2 months prior to presentation, he protein derivative test was negative. Anesthesiology and Biomedical had been employed repairing exterior brick on Bronchoalveolar lavage fluid was mucoid, and 3 Engineering and Division of three large apartment buildings (figure 1). This culture was negative. A transbronchial biopsy Thoracic/Foregut Surgery, University of Rochester, Rochester, required cutting through brick and mortar with a was nondiagnostic and the post-bronchoscopy 4Dept of Pathology, SUNY Upstate powered, high-speed demolition saw and grind- chest film showed a very small right apical pneu- Medical University, Syracuse, ing mortar from between bricks with a powered mothorax. An HIV test was negative. 5Dept of Pulmonary, Cayuga Medical Center, Ithaca, NY, and 6Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA. Correspondence: J.J. Lyons University of Rochester School of Medicine and Dentistry 601 Elmwood Ave Box 692 Rochester NY 14642 USA Fax: 1 5852731171 E-mail: jason_lyons@ urmc.rochester.edu Figure 2 Mason performing "tuck-pointing" on a brick building exterior, using a handheld powered mortar grinder, sim- ilar to that used by our patient. Field testing of air levels of dust in similar circumstances indicates that the parti- cle mask shown in the figure may not be adequate to Figure 1 protect against the high levels of dust generated. Brick apartment building whose exterior was renovated Photograph courtesy of the National Institute for by the patient. Occupational Safety and Health. 386 Breathe | June 2007 | Volume 3 | No 4 case presentations no03.qxd 17/05/2007 15:38 Page 3 A breathless builder CASE PRESENTATION a) There was no evidence of silicotic nodules on Figure 3 biopsy. Stains and cultures of lung tissue for a) Chest radiograph on emergent organisms were negative and a granulocyte presentation, with large right macrophage-colony stimulating factor (GM-CSF) pneumothorax and bilateral dif- antibody test was negative. fuse infiltrates. b) Chest CT prior to lung biopsy, showing bilateral and Additional examination of lung tissue diffuse alveolar filling. demonstrated macules of mixed opaque and birefringent dust associated with a mild degree of peribronchiolar and interstitial fibrosis (figure 5a). Much of the dust was strongly birefringent, typical of silicates, while a smaller amount of dust was weakly birefringent, consistent with crystalline silica (figure 5b). Scanning electron microscopy (SEM) of the b) lung tissue in situ in paraffin block (using vari- able pressure SEM to allow examination of non- conductive samples) identified individual parti- cles within macrophages in the lung tissue, and allowed energy-dispersive X-ray spectroscopy (EDS) analysis of their elemental content. This qualitative analysis showed numerous particles composed primarily of a mixture of aluminium silicates (found in standard red brick) and lesser amounts of silica (found in mortar; figure 6). There were rare particles of iron, titanium, iron with chromium and cerium. This was suffi- cient for a diagnosis of mixed dust pneumoco- Three days later, the patient developed acute niosis in addition to alveolar proteinosis [1]. The right-sided chest pain requiring urgent evalua- patient's employer was notified and given infor- tion. An initial physical examination revealed mation on the prevention of dust exposure in cyanosis without clubbing and faint inspiratory construction and the case was reported to the rales at the left base. Oxygen saturation was Occupational Lung Disease Registry of the state 80% on room air. The patient had a large right- health department. sided pneumothorax with bilateral diffuse airspace disease (figure 3a). Treatment After insertion of a chest tube, he continued For treatment of alveolar proteinosis, a left lung to have high oxygen requirements. Chest CT lavage was performed under general anaesthae- showed diffuse ground-glass opacities with an sia with a double lumen endotracheal tube upper lobe predominance (figure 3b). using the method described by KAO et al. [2] Video-assisted thoracoscopic surgery (VATS) with retrieval of ~20 L of milky-appearing lavage biopsy of the right upper lobe showed pul- fluid. The lavage fluid progressively cleared with monary alveolar proteinosis (PAP; figure 4). each aliquot. The procedure was uneventful with no oxy- gen desaturations noted. Unexpectedly, oxy- Figure 4 genation worsened several hours postlavage, Periodic acid Schiff stain of VATS resulting in ~1 week of mechanical ventilation biopsy showing alveolar filling without a significant improvement in oxygena- with proteinacious material (alve- tion. The patient was extubated and eventually olar proteinosis). Alveolar walls in discharged on 6 L per min continuous oxygen, this view show little or no cellular with a referral for lung transplantation. After infiltrate. several weeks at home he spontaneously experi- enced a second right pneumothorax, requiring rehospitalisation and chest tube drainage. Three months after the initial whole lung lavage, as part of his transplant evaluation, a repeat whole lung lavage was performed (this time bilateral) Breathe | June 2007 | Volume 3 | No 4 387 case presentations no03.qxd 17/05/2007 15:38 Page 4 CASE PRESENTATION A breathless builder Figure 5 a) b) a) Additional views of VATS biopsy material show dust-filled macrophages (arrows) with mild peribronchiolar and interstitial fibrosis (arrowheads). b) Polarised light microscopy of lung biopsy shows detail of one dust macule, with strongly birefringent dust, typical for silicates (arrow), and weakly birefringent particles, typical for crystalline silica (arrow- head). In addition to alveolar pro- teinosis, the biopsy fulfilled a) b) pathological criteria for mixed dust pneumoconiosis. Figure 6 SEM (backscattered electron images). EDS analysis shows parti- cles in macrophages as noted by light microscopy, including many particles too small to be visible by light microscopy. These were com- c) posed of a mixture of aluminium silicates, iron with chromium (steel) and silica (shown above). The white box (a) is enlarged in b. The blue cursor located over indi- vidual particles indicates the loca- tion from which the EDS spectrum (c) was collected. complicated by a third right-sided pneumothorax years. It was further defined by subsequent requiring tube thoracostomy. However, oxygena- authors [5, 6]. In a review of 34 cases, PRAKASH tion improved markedly and immediately, to the et al. [7] noted alveolar proteinosis as a non- degree that he needed no supplemental oxygen specific response to a variety of injuries including at rest, regained weight and markedly increased exposure to dusts, chemicals or infections, com- his activity level, though still requiring oxygen menting that its uncommon occurrence suggests with exertion. A repeat chest CT showed reduc- individual susceptibility as an important factor tion in the alveolar filling process after the sec- in its aetiology [7, 8]. Alveolar proteinosis has ond whole lung lavage. been reproduced in a rat model by instillation of silica dust into the lungs [9]. The high preva- Discussion lence of current or past smoking suggests that PAP may be the following: congenital, due to smoking, which involves chronic inhalational mutations in surfactant or GM-CSF genes; sec- exposures to very small combustion particles, ondary to haematologic cancers, immunosup- may be a risk factor [3, 10]. pression or dust; or acquired (idiopathic), which Before the availability of lung transplanta- is in some cases an autoimmune process target- tion, silicoproteinosis had been described as hav- ing GM-CSF [3]. Weight loss and susceptibility to ing a uniformly fatal course [11, 12]. recurrent infections are clinical characteristics. The current patient presented with the clini- The development of PAP is a well-described com- cal picture of silicoproteinosis, but in the context plication of severe silicosis termed acute silicosis of mixed dust exposure with prominent alveolar or silicoproteinosis. Acute silicosis was described proteinosis and less prominent mixed dust fibro- in 1900 by BETTS [4] in a case series of 30 fatal- sis rather than silicosis. Mixed dust pneumoco- ities of males working in a single mineral ore niosis is caused by inhalation of a mixture of sil- crushing mill whose mean age at death was 30 ica and nonsilica dust, including coal, talc, 388 Breathe | June 2007 | Volume 3 | No 4 case presentations no03.qxd 17/05/2007 15:38 Page 5 A breathless builder CASE PRESENTATION and/or other silicates. It has recently been Alveolar proteinosis is often but not always defined pathologically as "pneumoconiosis responsive to whole lung lavage, which has been showing dust macules or mixed-dust fibrotic described as a stop-gap therapy for a condition nodules, with or without silicotic nodules, in an that needs definitive treatment of the underlying individual with a history of exposure to mixed process [18]. The current patient's adverse dust" [1].
Recommended publications
  • Occupational Airborne Particulates
    Environmental Burden of Disease Series, No. 7 Occupational airborne particulates Assessing the environmental burden of disease at national and local levels Tim Driscoll Kyle Steenland Deborah Imel Nelson James Leigh Series Editors Annette Prüss-Üstün, Diarmid Campbell-Lendrum, Carlos Corvalán, Alistair Woodward World Health Organization Protection of the Human Environment Geneva 2004 WHO Library Cataloguing-in-Publication Data Occupational airborne particulates : assessing the environmental burden of disease at national and local levels / Tim Driscoll … [et al.]. (Environmental burden of disease series / series editors: Annette Prüss-Ustun ... [et al.] ; no. 7) 1.Dust - adverse effects 2.Occupational exposure 3.Asthma - chemically induced 4.Pulmonary disease, Chronic obstructive - chemically induced 5.Pneumoconiosis - etiology 6.Cost of illness 7.Epidemiologic studies 8.Risk assessment - methods 9.Manuals I.Driscoll, Tim. II.Prüss-Üstün, Annette. III.Series. ISBN 92 4 159186 2 (NLM classification: WA 450) ISSN 1728-1652 Suggested Citation Tim Driscoll, et al. Occupational airborne particulates: assessing the environmental burden of disease at national and local levels. Geneva, World Health Organization, 2004. (Environmental Burden of Disease Series, No. 7). © World Health Organization 2004 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]).
    [Show full text]
  • Ep001476158b1*
    (19) *EP001476158B1* (11) EP 1 476 158 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/455 (2006.01) A61P 29/00 (2006.01) 14.11.2007 Bulletin 2007/46 A61P 11/00 (2006.01) C07D 405/12 (2006.01) C07D 213/82 (2006.01) C07D 401/12 (2006.01) (2006.01) (21) Application number: 03739392.3 C07D 451/04 (22) Date of filing: 03.02.2003 (86) International application number: PCT/IB2003/000439 (87) International publication number: WO 2003/068235 (21.08.2003 Gazette 2003/34) (54) NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS NICOTINAMID-DERIVATE ALS PDE4-HEMMER DERIVES DE NICOTINAMIDE UTILES COMME INHIBITEURS DE PDE4 (84) Designated Contracting States: • HENDERSON, A.J., AT BE BG CH CY CZ DE DK EE ES FI FR GB GR c/o UK Patent Dept., HU IE IT LI LU MC NL PT SE SI SK TR Pfizer Ltd. Designated Extension States: Sandwich, Kent CT13 9NJ (GB) AL LT LV MK RO • MAGEE, T.V., c/o Pfizer Global Res. and Develop. (30) Priority: 11.02.2002 GB 0203196 Groton, CT 06340 (US) 10.09.2002 GB 0220999 • MARFAT, A., 21.10.2002 GB 0224453 c/o Pfizer Global Res. and Develop. 20.11.2002 GB 0227139 Groton, CT 06340 (US) • MATHIAS, J.P., (43) Date of publication of application: c/o Pfizer Global Res. and Develop. 17.11.2004 Bulletin 2004/47 Sandwich, Kent CT13 9NJ (GB) (73) Proprietors: • MCLEOD, D.G., • Pfizer Limited c/o Pfizer Global Res.
    [Show full text]
  • Pneumoconiosis
    Prim Care Respir J 2013; 22(2): 249-252 PERSPECTIVE Pneumoconiosis *Paul Cullinan1, Peter Reid2 1 Consultant Physician, Royal Brompton and Harefield NHS Foundation Trust, London, UK 2 Consultant Physician, Western General Hospital, Edinburgh, UK Introduction Figure 1. Asbestosis; the HRCT scan shows the typical The pneumoconioses are parenchymal lung diseases that arise from picture of subpleural fibrosis (solid arrow); in addition inhalation of (usually) inorganic dusts at work. Some such dusts are there is diffuse, left-sided pleural thickening (broken biologically inert but visible on a chest X-ray or CT scan; thus, while arrow), characteristic too of heavy asbestos exposure they are radiologically alarming they do not give rise to either clinical disease or deficits in pulmonary function. Others – notably asbestos and crystalline silica – are fibrogenic so that the damage they cause is through the fibrosis induced by the inhaled dust rather than the dust itself. Classically these give rise to characteristic radiological patterns and restrictive deficits in lung function with reductions in diffusion capacity; importantly, they may progress long after exposure to the causative mineral has finished. In the UK and similar countries asbestosis is the commonest form of pneumoconiosis but in less developed parts of the world asbestosis is less frequent than silicosis; these two types are discussed in detail below. Other, rarer types of pneumoconiosis include stannosis (from tin fume), siderosis (iron), berylliosis (beryllium), hard metal disease (cobalt) and coal worker’s pneumoconiosis. Asbestosis Clinical scenario How is the diagnosis made? Asbestosis is the ‘pneumoconiosis’ that arises from exposure to A man of 78 reports gradually worsening breathlessness; he has asbestos in the workplace.1 The diagnosis is made when, on the no relevant medical history of note and has never been a regular background of heavy occupational exposure to any type of asbestos, smoker.
    [Show full text]
  • Pneumoconiosis in Coalminers
    6I8 POSTGRADUATE MEDICAL JOURNAL December I949 Postgrad Med J: first published as 10.1136/pgmj.25.290.618 on 1 December 1949. Downloaded from IRVINE, L. G., SIMSON, F. W., and STRACHAN, A. S. (1930), NEW YORK STATE DEPARTMENT OF LABOUR (1949), Proc. Intern. Conf. on Silicosis in Johannesburg, I.L.O. Studies Monthly Review, 28, No. 4, April. and Reports, Series F. (Industrial Hygiene), No. I3, p. 259. PERRY, K. M. A. (1948), Proc. Ninth Intern. Cong. of Ind. Med., JONES, W. R. (I933), ,. of Hyg., 33, 307. London (in the press). KETTLE, E. H. (I932), Y. Path. and Bat., 35, 395. KETTLE, E. H. (I934), Ibid., 38, 20o. POLICARD, A. (1947), Proc. Conf. of the Institution of Mining KING, E. J. (I945), M.R.C. Special Report Series, No. 250, p. 73. Engineers and Institution of Mining and Metalurgy, London, KING, E. J. (I947) Occ. Med., 4, 26. P. 24. KING, E. J., WRI6HT, B. M., and RAY, S. C. (I949), Paper read ROGERS, E. (i944), Paper read to the British Tuberculosis Associa- to the Path. Soc., Great Britain, January, 1949. tion. McLAUGHLIN, A. I. G., ROGERS, E., and DUNHAM, K. C. (I949), Brit. 3Y. Ind. Med., 6, I84. SHAVER, C. G. (1948), Radiology, 50, 760. MINERS' PHTHISIS MEDICAL BUREAU OF SOUTH SHAVER, C. G., and RIDDELL, A. R. (I947), J. Id. Hyg. and AFRICA (1946), Report for the Three Years ending Jy 31, Tox., 29, 145. I944 (South African Government Printer). VORWALD, A. J., and CARR, J. W. (1938), Amer. J7. Path., 14,49. PNEUMOCONIOSIS IN COAL MINERS By J.
    [Show full text]
  • Progressive Plasterer's Pneumoconiosis Complicated By
    Kurosaki et al. BMC Pulmonary Medicine (2019) 19:6 https://doi.org/10.1186/s12890-018-0776-4 CASEREPORT Open Access Progressive plasterer’s pneumoconiosis complicated by fibrotic interstitial pneumonia: a case report Fumio Kurosaki1,2*, Tamiko Takemura3, Masashi Bando1, Tomonori Kuroki1,2, Toshio Numao2, Hiroshi Moriyama4 and Koichi Hagiwara1 Abstract Background: Although the prevalence of pneumoconiosis has been decreasing due to improvements in working conditions and regular health examinations, occupational hygiene measures are still being established. Plasterers encounter a number of hazardous materials that may be inhaled in the absence of sufficient protection. Case presentation: A 64-year-old man who plastered without any dust protection for more than 40 years was referred to our hospital with suspected interstitial pneumonia. Mixed dust pneumoconiosis and an unusual interstitial pneumonia (UIP) pattern with fibroblastic foci were diagnosed by video-assisted thoracoscopic surgery, and an elemental analysis detected elements included in plaster work materials. Despite the cessation of plaster work and administration of nintedanib, the patient developed advanced respiratory failure. Conclusion: Plasterers are at an increased risk of pneumoconiosis and may have a poor prognosis when complicated by the UIP pattern. Thorough dust protection and careful monitoring are needed. Keywords: Plasterer, Pneumoconiosis, Usual interstitial pneumonia, Elemental analysis Background unusual interstitial pneumonia (UIP) pattern, the cause of With energy transition from coal to oil and nuclear power, which was identified as plaster work by an elemental coal mines completely disappeared by the early first analysis. Therefore, plasterers need to take proper coun- decade of the 2000s in Japan. Furthermore, improvements termeasures for dust prevention and undergo regular in industrial hygiene and vocational education have examinations.
    [Show full text]
  • Misclassification of Occupational Disease in Lung Transplant Recipients
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author J Heart Manuscript Author Lung Transplant Manuscript Author . Author manuscript; available in PMC 2017 November 13. Published in final edited form as: J Heart Lung Transplant. 2017 May ; 36(5): 588–590. doi:10.1016/j.healun.2017.02.021. Misclassification of occupational disease in lung transplant recipients David J. Blackley, DrPHa, Cara N. Halldin, PhDa, Robert A. Cohen, MDa,b, Kristin J. Cummings, MDa, Eileen Storey, MDa, and A. Scott Laney, PhDa aRespiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, USA bSchool of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA Data from the United States Organ Procurement and Transplantation Network (OPTN) registry have been analyzed in recent years to assess post–lung transplant (LT) survival in occupational lung disease patients.1–3 Registry data include diagnosis codes with limited specificity; each patient is assigned a diagnosis code at waitlist candidacy, at listing, and at LT, and these codes can differ. The use of both numeric and free-text data can produce incompatible or unlikely diagnosis code pairings (such as a numeric code for idiopathic pulmonary fibrosis with a paired free-text entry of “silicosis”). The resulting misclassification could bias findings related to patient characteristics, post-LT survival comparisons and other measures used to summarize outcomes. Diagnosis codes from OPTN data could be inadequate for case finding and may result in missed occupational lung disease cases. Our objective was to identify and describe adult LT recipients documented as having conditions known to be entirely attributable to occupational exposure, and to calculate the proportion of those patients who were assigned an occupational lung disease diagnosis code at LT.
    [Show full text]
  • European Respiratory Society Classification of the Idiopathic
    This copy is for personal use only. To order printed copies, contact [email protected] 1849 CHEST IMAGING American Thoracic Society– European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 20021 Nicola Sverzellati, MD, PhD David A. Lynch, MB In the updated American Thoracic Society–European Respira- David M. Hansell, MD, FRCP, FRCR tory Society classification of the idiopathic interstitial pneumonias Takeshi Johkoh, MD, PhD (IIPs), the major entities have been preserved and grouped into Talmadge E. King, Jr, MD (a) “chronic fibrosing IIPs” (idiopathic pulmonary fibrosis and id- William D. Travis, MD iopathic nonspecific interstitial pneumonia), (b) “smoking-related IIPs” (respiratory bronchiolitis–associated interstitial lung disease Abbreviations: H-E = hematoxylin-eosin, and desquamative interstitial pneumonia), (c) “acute or subacute IIP = idiopathic interstitial pneumonia, IPF = IIPs” (cryptogenic organizing pneumonia and acute interstitial idiopathic pulmonary fibrosis, NSIP = nonspe- cific interstitial pneumonia, RB-ILD = respi- pneumonia), and (d) “rare IIPs” (lymphoid interstitial pneumonia ratory bronchiolitis–associated interstitial lung and idiopathic pleuroparenchymal fibroelastosis). Furthermore, it disease, UIP = usual interstitial pneumonia has been acknowledged that a final diagnosis is not always achiev- RadioGraphics 2015; 35:1849–1872 able, and the category “unclassifiable IIP” has been proposed. The Published online 10.1148/rg.2015140334 diagnostic interpretation of
    [Show full text]
  • Pneumoconiosis and Byssinosis
    British Journal of Industrial Medicine, 1974, 31, 322-328 Br J Ind Med: first published as 10.1136/oem.31.4.322 on 1 October 1974. Downloaded from Notes and miscellanea Pneumoconiosis and byssinosis D. C. F. MUIR Institute of Occupational Medicine, Roxburgh Place, Edinburgh, EH8 9SU On 1 August 1968 the Minister of Social Security loggerheads over the question of pneumoconiosis in referred the following question to the Industrial general and of related disability in particular. Injuries Advisory Council for consideration and The less controversial aspects of the report should advice: perhaps be mentioned first in order to clear the way Whether in the light of experience and current for a review of its more fundamental features. It is knowledge any adjustment should be made in the well written and has concise and clear explanations terms of the definition of pneumoconiosis in of the problems considered. The historical back- section 58 (3) of the National Insurance (In- ground is reviewed in detail, and there is an excellent copyright. dustrial Injuries) Act 1965; and whether any and, description of the work of the Pneumoconiosis if so, what special provision should be made for Medical Panels. There is a great deal of information disablement due to other respiratory conditions in the report which is not available in textbooks of found in the presence of such pneumoconiosis to occupational medicine, and it should be essential be taken into account in assessing the extent of reading for all who have an interest in this field. The disablement due to the disease. summary and conclusions are short and explicit.
    [Show full text]
  • Original Article
    Artigo Original Broncoscopia no diagnóstico de tuberculose pulmonar em pacientes com baciloscopia de escarro negativa* Bronchoscopy for the diagnosis of pulmonary tuberculosis in patients with negative sputum smear microscopy results Márcia Jacomelli, Priscila Regina Alves Araújo Silva, Ascedio Jose Rodrigues, Sergio Eduardo Demarzo, Márcia Seicento, Viviane Rossi Figueiredo Resumo Objetivo: Avaliar a acurácia diagnóstica da broncoscopia em pacientes com suspeita clínica ou radiológica de tuberculose, com baciloscopia negativa ou incapazes de produzir escarro. Métodos: Estudo transversal prospectivo de 286 pacientes com suspeita clínica/radiológica de tuberculose pulmonar e submetidos à broncoscopia — LBA e biópsia transbrônquica (BTB). As amostras de LBA foram testadas por pesquisas diretas e culturas de BAAR e de fungos, e as de BTB por exame histopatológico. Resultados: Dos 286 pacientes estudados, a broncoscopia contribuiu para o diagnóstico em 225 (79%): tuberculose pulmonar em 127 (44%); inflamações crônicas inespecíficas em 51 (18%); pneumocistose, infecções fúngicas ou nocardiose em 20 (7%); bronquiolite obliterante com pneumonia em organização, alveolites ou pneumoconioses em 14 (5%); neoplasias pulmonares ou metastáticas em 7 (2%); e micobacterioses não tuberculosas em 6 (2%). Para o diagnóstico de tuberculose, o LBA mostrou sensibilidade e especificidade de 60% e 100% respectivamente, havendo um aumento importante da sensibilidade quando associado à biópsia (84%) e à baciloscopia após a broncoscopia (94%). Complicações controláveis decorrentes do procedimento ocorreram em 5,6% dos casos. Conclusões: A broncoscopia representa um método diagnóstico confiável para pacientes com tuberculose pulmonar, apresentando baixos índices de complicações. A associação de biópsia transbrônquica ao lavado broncoalveolar elevou a sensibilidade diagnóstica do método e permitiu o diagnóstico diferencial com outras doenças.
    [Show full text]
  • Respirable Crystalline Silica: Its History, Associated Disease, and the New OSHA Standard—Understanding the New Regulations
    Respirable Crystalline Silica: Its History, Associated Disease, and the New OSHA Standard—Understanding the New Regulations The Occupational Safety and Health Administration (OSHA) issued its new silica ruling on June 23, 2015 to take effect one year later. The new ruling (the Final Rule) allows industry from one to five years to comply with most requirements. The Construction Industry must comply by June 23, 2017, while Maritime and General Industry have until June 23, 2018. According to OSHA, the estimated impact of the new ruling translates to more than 600 lives saved and a reduction of more than 900 new cases of silicosis each year. The Final Rule is projected to provide net benefits of about $7.7 billion annually. There are, of course, opponents to this new regulation who deem the ruling requirements to be not only technologically and economically unfeasible, but also unnecessary. Opponents point to a Centers of Disease Control statistic which states that silica-related deaths have dropped by 93 percent from 1968 to 2007. They also believe OSHA’s cost estimate for implementation of the new rule is inaccurate and unrealistic. While OSHA projects the program to cost $511 million for companies to comply, opponents estimate the total costs will tally to nearly $5 billion.1 This paper covers: • Historical background of occupational silicosis • Industrial sources of silica exposures • Occupational illnesses caused by silica exposure • Comparison of the current regulation to the new regulation • Method to incorporate compliance practices
    [Show full text]
  • Cryptogenic Organizing Pneumonia
    462 Cryptogenic Organizing Pneumonia Vincent Cottin, M.D., Ph.D. 1 Jean-François Cordier, M.D. 1 1 Hospices Civils de Lyon, Louis Pradel Hospital, National Reference Address for correspondence and reprint requests Vincent Cottin, Centre for Rare Pulmonary Diseases, Competence Centre for M.D., Ph.D., Hôpital Louis Pradel, 28 avenue Doyen Lépine, F-69677 Pulmonary Hypertension, Department of Respiratory Medicine, Lyon Cedex, France (e-mail: [email protected]). University Claude Bernard Lyon I, University of Lyon, Lyon, France Semin Respir Crit Care Med 2012;33:462–475. Abstract Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of fibroblasts and myofibroblasts intermixed with loose connective matrix. This pattern is the hallmark of a clinical pathological entity, namely cryptogenic organizing pneumonia (COP) when no cause or etiologic context is found. The process of intraalveolar organization results from a sequence of alveolar injury, alveolar deposition of fibrin, and colonization of fibrin with proliferating fibroblasts. A tremen- dous challenge for research is represented by the analysis of features that differentiate the reversible process of OP from that of fibroblastic foci driving irreversible fibrosis in usual interstitial pneumonia because they may determine the different outcomes of COP and idiopathic pulmonary fibrosis (IPF), respectively. Three main imaging patterns of COP have been described: (1) multiple patchy alveolar opacities (typical pattern), (2) solitary focal nodule or mass (focal pattern), and (3) diffuse infiltrative opacities, although several other uncommon patterns have been reported, especially the reversed halo sign (atoll sign).
    [Show full text]
  • BTS Interstitial Lung Disease Guideline
    BTS guideline Thorax: first published as 10.1136/thx.2008.101691 on 24 September 2008. Downloaded from Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society A U Wells,1 N Hirani,2 on behalf of the British Thoracic Society Interstitial Lung Disease Guideline Group, a subgroup of the British Thoracic Society Standards of Care Committee, in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society c Additional information is 1. INTRODUCTION aspects in the process of writing the ILD guidelines published in the online 1.1 An overview of the ILD guideline that merit explanation. appendices (2, 5–11) at http:// 1. These are the first BTS guidelines to have thorax.bmj.com/content/vol63/ Since the publication of the first BTS guidelines for been written in conjunction with other issueSupplV diffuse lung disease nearly 10 years ago,1 the 1 international bodies, namely the Thoracic Royal Brompton Hospital, specialty has seen considerable change. The early Interstitial Lung Disease Unit, Society of Australia and New Zealand and London, UK; 2 Royal Infirmary discussions of the Guideline Group centred upon the Irish Thoracic Society. It is hoped that, by Edinburgh, Edinburgh, UK whether the revised document might consist of the broadening the collaborative base, the quality 1999 document with minor adaptations. However, and credibility of the guidelines has been Correspondence to: it was considered that too much change had taken enhanced and the document will reach a Dr N Hirani, Royal Infirmary Edinburgh, Little France place in the intervening years to justify a simple wider readership.
    [Show full text]